Authors
Loading...
In vitro study demonstrates selective inhibition of amyloid-beta fibril formation by HMP bromide, indicating a specific amphipathic binding site for anti-amyloid therapeutics.
Wood et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: